메뉴 건너뛰기




Volumn 111, Issue 1, 2014, Pages 1-10

Is there a role for proton therapy in the treatment of hepatocellular carcinoma? A systematic review

Author keywords

Hepatocellular carcinoma; Proton therapy; Systematic review

Indexed keywords

IODINATED POPPYSEED OIL; PROTON; CONTRAST MEDIUM;

EID: 84902196263     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.02.001     Document Type: Review
Times cited : (48)

References (71)
  • 2
    • 63049133092 scopus 로고    scopus 로고
    • Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
    • S.F. Altekruse, K.A. McGlynn, and M.E. Reichman Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005 J Clin Oncol 27 2009 1485 1491
    • (2009) J Clin Oncol , vol.27 , pp. 1485-1491
    • Altekruse, S.F.1    McGlynn, K.A.2    Reichman, M.E.3
  • 3
    • 49349109364 scopus 로고    scopus 로고
    • Recent advances in the natural history of hepatocellular carcinoma
    • F. Trevisani, M.C. Cantarini, J.R. Wands, and M. Bernardi Recent advances in the natural history of hepatocellular carcinoma Carcinogenesis 29 2008 1299 1305
    • (2008) Carcinogenesis , vol.29 , pp. 1299-1305
    • Trevisani, F.1    Cantarini, M.C.2    Wands, J.R.3    Bernardi, M.4
  • 4
    • 0032898237 scopus 로고    scopus 로고
    • Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials
    • J.M. Llovet, J. Bustamante, and A. Castells et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials Hepatology 29 1999 62 67
    • (1999) Hepatology , vol.29 , pp. 62-67
    • Llovet, J.M.1    Bustamante, J.2    Castells, A.3
  • 5
    • 77952081222 scopus 로고    scopus 로고
    • Management of small hepatocellular carcinoma: A review of transplantation, resection, and ablation
    • W.R. Jarnagin Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation Ann Surg Oncol 17 2010 1226 1233
    • (2010) Ann Surg Oncol , vol.17 , pp. 1226-1233
    • Jarnagin, W.R.1
  • 6
    • 13844280344 scopus 로고    scopus 로고
    • Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation
    • R. Lencioni, D. Cioni, and L. Crocetti et al. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967
    • (2005) Radiology , vol.234 , pp. 961-967
    • Lencioni, R.1    Cioni, D.2    Crocetti, L.3
  • 7
    • 79960748644 scopus 로고    scopus 로고
    • Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
    • L. Tiong, and G.J. Maddern Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma Br J Surg 98 2011 1210 1224
    • (2011) Br J Surg , vol.98 , pp. 1210-1224
    • Tiong, L.1    Maddern, G.J.2
  • 8
    • 0037308133 scopus 로고    scopus 로고
    • Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
    • J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
    • (2003) Hepatology , vol.37 , pp. 429-442
    • Llovet, J.M.1    Bruix, J.2
  • 9
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • J.M. Llovet, C. Brú, and J. Bruix Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 1999 329 338
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Brú, C.2    Bruix, J.3
  • 11
    • 33644833948 scopus 로고    scopus 로고
    • Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies
    • E. Ben-Josef, D. Normolle, and W.D. Ensminger et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies J Clin Oncol 23 2005 8739 8747
    • (2005) J Clin Oncol , vol.23 , pp. 8739-8747
    • Ben-Josef, E.1    Normolle, D.2    Ensminger, W.D.3
  • 12
    • 39149134352 scopus 로고    scopus 로고
    • Phase i study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma
    • R.V. Tse, M. Hawkins, and G. Lockwood et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 2008 657 664
    • (2008) J Clin Oncol , vol.26 , pp. 657-664
    • Tse, R.V.1    Hawkins, M.2    Lockwood, G.3
  • 13
    • 84995268963 scopus 로고
    • EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma
    • EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma Eur J Cancer 2012 1990 599 641
    • (1990) Eur J Cancer , vol.2012 , pp. 599-641
  • 16
    • 84859721819 scopus 로고    scopus 로고
    • Charged particles in radiotherapy: A 5-year update of a systematic review
    • D. De Ruysscher, M. Mark Lodge, and B. Jones et al. Charged particles in radiotherapy: a 5-year update of a systematic review Radiother Oncol 103 2012 5 7
    • (2012) Radiother Oncol , vol.103 , pp. 5-7
    • De Ruysscher, D.1    Mark Lodge, M.2    Jones, B.3
  • 17
    • 68549101842 scopus 로고    scopus 로고
    • The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration
    • A. Liberati, D.G. Altman, and J. Tetzlaff et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
    • (2009) BMJ , vol.339 , pp. 2700
    • Liberati, A.1    Altman, D.G.2    Tetzlaff, J.3
  • 18
    • 79959604264 scopus 로고    scopus 로고
    • The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: A phase 2 prospective trial
    • D.A. Bush, Z. Kayali, R. Grove, and J.D. Slater The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial Cancer 117 2011 3053 3059
    • (2011) Cancer , vol.117 , pp. 3053-3059
    • Bush, D.A.1    Kayali, Z.2    Grove, R.3    Slater, J.D.4
  • 19
    • 21044437643 scopus 로고    scopus 로고
    • Proton beam therapy for hepatocellular carcinoma: A retrospective review of 162 patients
    • T. Chiba, K. Tokuuye, and Y. Matsuzaki et al. Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients Clin Cancer Res 11 2005 3799 3805
    • (2005) Clin Cancer Res , vol.11 , pp. 3799-3805
    • Chiba, T.1    Tokuuye, K.2    Matsuzaki, Y.3
  • 20
    • 72249099451 scopus 로고    scopus 로고
    • Proton beam therapy for hepatocellular carcinoma: The University of Tsukuba experience
    • H. Nakayama, S. Sugahara, and M. Tokita et al. Proton beam therapy for hepatocellular carcinoma: the University of Tsukuba experience Cancer 115 2009 5499 5506
    • (2009) Cancer , vol.115 , pp. 5499-5506
    • Nakayama, H.1    Sugahara, S.2    Tokita, M.3
  • 21
    • 80054793652 scopus 로고    scopus 로고
    • Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma
    • S. Komatsu, T. Fukumoto, and Y. Demizu et al. Clinical results and risk factors of proton and carbon ion therapy for hepatocellular carcinoma Cancer 117 2011 4890 4904
    • (2011) Cancer , vol.117 , pp. 4890-4904
    • Komatsu, S.1    Fukumoto, T.2    Demizu, Y.3
  • 22
    • 84902161147 scopus 로고    scopus 로고
    • Pilot study of respiratory gated proton beam therapy for liver tumors
    • T.S. Hong, T.F. DeLaney, and H.J. Mamon et al. Pilot study of respiratory gated proton beam therapy for liver tumors Int J Radiat Oncol Biol Phys 75 2009 S166
    • (2009) Int J Radiat Oncol Biol Phys , vol.75 , pp. 166
    • Hong, T.S.1    Delaney, T.F.2    Mamon, H.J.3
  • 24
    • 84920670671 scopus 로고    scopus 로고
    • Proton therapy for hepatocellular carcinoma
    • WPTC, China
    • Lee J. Proton therapy for hepatocellular carcinoma, presented at PTCOG 46, WPTC, China, avalaible at http://ptcog.web.psi.ch/ptcog46-talks.html.
    • PTCOG , vol.46
    • Lee, J.1
  • 25
    • 84855850266 scopus 로고    scopus 로고
    • Investigation of the geometric accuracy of proton beam irradiation in the liver
    • N. Fukumitsu, T. Hashimoto, and T. Okumura et al. Investigation of the geometric accuracy of proton beam irradiation in the liver Int J Radiat Oncol Biol Phys 82 2012 826 833
    • (2012) Int J Radiat Oncol Biol Phys , vol.82 , pp. 826-833
    • Fukumitsu, N.1    Hashimoto, T.2    Okumura, T.3
  • 26
    • 79958097023 scopus 로고    scopus 로고
    • Displacement of hepatic tumor at time to exposure in end-expiratory- triggered-pulse proton therapy
    • Y. Oshiro, T. Okumura, and M. Ishida et al. Displacement of hepatic tumor at time to exposure in end-expiratory-triggered-pulse proton therapy Radiother Oncol 99 2011 124 130
    • (2011) Radiother Oncol , vol.99 , pp. 124-130
    • Oshiro, Y.1    Okumura, T.2    Ishida, M.3
  • 27
    • 52949135918 scopus 로고    scopus 로고
    • Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma
    • D. Shin, T.H. Kim, and S.Y. Park et al. Influence of lipiodol agent on proton beam range in radiotherapy planning using computed tomography for hepatocellular carcinoma Int J Radiat Oncol Biol Phys 72 2008 687 694
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 687-694
    • Shin, D.1    Kim, T.H.2    Park, S.Y.3
  • 28
    • 34547777895 scopus 로고    scopus 로고
    • Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites: Technical considerations and results
    • M. Hata, K. Tokuuye, and S. Sugahara et al. Proton irradiation in a single fraction for hepatocellular carcinoma patients with uncontrollable ascites: technical considerations and results Strahlenther Onkol 183 2007 411 416
    • (2007) Strahlenther Onkol , vol.183 , pp. 411-416
    • Hata, M.1    Tokuuye, K.2    Sugahara, S.3
  • 30
    • 84856402815 scopus 로고    scopus 로고
    • Evaluation of liver function after proton beam therapy for hepatocellular carcinoma
    • M. Mizumoto, T. Okumura, and T. Hashimoto et al. Evaluation of liver function after proton beam therapy for hepatocellular carcinoma Int J Radiat Oncol Biol Phys 82 2012 e529 e535
    • (2012) Int J Radiat Oncol Biol Phys , vol.82
    • Mizumoto, M.1    Okumura, T.2    Hashimoto, T.3
  • 31
    • 84875207831 scopus 로고    scopus 로고
    • Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma
    • A. Kanemoto, M. Mizumoto, and T. Okumura et al. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma Acta Oncol 52 2013 538 544
    • (2013) Acta Oncol , vol.52 , pp. 538-544
    • Kanemoto, A.1    Mizumoto, M.2    Okumura, T.3
  • 32
    • 0030802543 scopus 로고    scopus 로고
    • Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: Analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy
    • K. Ohara, T. Okumura, and H. Tsuji et al. Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy Int J Radiat Oncol Biol Phys 38 1997 367 372
    • (1997) Int J Radiat Oncol Biol Phys , vol.38 , pp. 367-372
    • Ohara, K.1    Okumura, T.2    Tsuji, H.3
  • 33
    • 79952699828 scopus 로고    scopus 로고
    • Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma
    • M. Kawashima, R. Kohno, and K. Nakachi et al. Dose-volume histogram analysis of the safety of proton beam therapy for unresectable hepatocellular carcinoma Int J Radiat Oncol Biol Phys 79 2011 1479 1486
    • (2011) Int J Radiat Oncol Biol Phys , vol.79 , pp. 1479-1486
    • Kawashima, M.1    Kohno, R.2    Nakachi, K.3
  • 34
    • 15744390289 scopus 로고    scopus 로고
    • Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma
    • M. Kawashima, J. Furuse, and T. Nishio et al. Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma J Clin Oncol 23 2005 1839 1846
    • (2005) J Clin Oncol , vol.23 , pp. 1839-1846
    • Kawashima, M.1    Furuse, J.2    Nishio, T.3
  • 35
    • 0345299824 scopus 로고    scopus 로고
    • Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    • V. Mazzaferro, E. Regalia, and R. Doci et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
    • (1996) N Engl J Med , vol.334 , pp. 693-699
    • Mazzaferro, V.1    Regalia, E.2    Doci, R.3
  • 36
    • 0021717794 scopus 로고
    • A multiple regression equation for prediction of posthepatectomy liver failure
    • N. Yamanaka, E. Okamoto, K. Kuwata, and N. Tanaka A multiple regression equation for prediction of posthepatectomy liver failure Ann Surg 200 1984 658 663
    • (1984) Ann Surg , vol.200 , pp. 658-663
    • Yamanaka, N.1    Okamoto, E.2    Kuwata, K.3    Tanaka, N.4
  • 37
    • 54349105099 scopus 로고    scopus 로고
    • Proton radiotherapy for liver tumors: Dosimetric advantages over photon plans
    • X. Wang, S. Krishnan, and X. Zhang et al. Proton radiotherapy for liver tumors: dosimetric advantages over photon plans Med Dosim 33 2008 259 267
    • (2008) Med Dosim , vol.33 , pp. 259-267
    • Wang, X.1    Krishnan, S.2    Zhang, X.3
  • 39
    • 33646029747 scopus 로고    scopus 로고
    • Radiation therapy for hepatocellular carcinoma: From palliation to cure
    • M.A. Hawkins, and L.A. Dawson Radiation therapy for hepatocellular carcinoma: from palliation to cure Cancer 106 2006 1653 1663
    • (2006) Cancer , vol.106 , pp. 1653-1663
    • Hawkins, M.A.1    Dawson, L.A.2
  • 40
    • 84863182803 scopus 로고    scopus 로고
    • Improved radiotherapy for primary and secondary liver cancer: Stereotactic body radiation therapy
    • C. Tao, and L.-X. Yang Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapy Anticancer Res 32 2012 649 655
    • (2012) Anticancer Res , vol.32 , pp. 649-655
    • Tao, C.1    Yang, L.-X.2
  • 42
    • 47949116252 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • J.M. Llovet, S. Ricci, and V. Mazzaferro et al. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378 390
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3
  • 43
    • 67650896445 scopus 로고    scopus 로고
    • Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    • M.-B. Meng, Y.-L. Cui, and Y. Lu et al. Transcatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysis Radiother Oncol 92 2009 184 194
    • (2009) Radiother Oncol , vol.92 , pp. 184-194
    • Meng, M.-B.1    Cui, Y.-L.2    Lu, Y.3
  • 45
    • 84883051033 scopus 로고    scopus 로고
    • Sequential phase i and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma
    • A. Bujold, C.A. Massey, and J.J. Kim et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma J Clin Oncol 31 2013 1631 1639
    • (2013) J Clin Oncol , vol.31 , pp. 1631-1639
    • Bujold, A.1    Massey, C.A.2    Kim, J.J.3
  • 46
    • 79959359429 scopus 로고    scopus 로고
    • Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract
    • H. Nakayama, S. Sugahara, and K. Fukuda et al. Proton beam therapy for hepatocellular carcinoma located adjacent to the alimentary tract Int J Radiat Oncol Biol Phys 80 2011 992 995
    • (2011) Int J Radiat Oncol Biol Phys , vol.80 , pp. 992-995
    • Nakayama, H.1    Sugahara, S.2    Fukuda, K.3
  • 47
    • 79952005824 scopus 로고    scopus 로고
    • Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma
    • S. Komatsu, M. Murakami, T. Fukumoto, Y. Hori, Y. Hishikawa, and Y. Ku Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma Br J Surg 98 2011 558 564
    • (2011) Br J Surg , vol.98 , pp. 558-564
    • Komatsu, S.1    Murakami, M.2    Fukumoto, T.3    Hori, Y.4    Hishikawa, Y.5    Ku, Y.6
  • 48
    • 43049157525 scopus 로고    scopus 로고
    • Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis
    • M. Mizumoto, K. Tokuuye, and S. Sugahara et al. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis Int J Radiat Oncol Biol Phys 71 2008 462 467
    • (2008) Int J Radiat Oncol Biol Phys , vol.71 , pp. 462-467
    • Mizumoto, M.1    Tokuuye, K.2    Sugahara, S.3
  • 49
    • 84875225402 scopus 로고    scopus 로고
    • Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system
    • T. Eriguchi, A. Takeda, and N. Sanuki et al. Acceptable toxicity after stereotactic body radiation therapy for liver tumors adjacent to the central biliary system Int J Radiat Oncol Biol Phys 85 2013 1006 1011
    • (2013) Int J Radiat Oncol Biol Phys , vol.85 , pp. 1006-1011
    • Eriguchi, T.1    Takeda, A.2    Sanuki, N.3
  • 50
    • 77958511341 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication
    • S.H. Son, B.O. Choi, and M.R. Ryu et al. Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication Int J Radiat Oncol Biol Phys 78 2010 1073 1080
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , pp. 1073-1080
    • Son, S.H.1    Choi, B.O.2    Ryu, M.R.3
  • 51
    • 84863522446 scopus 로고    scopus 로고
    • The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma
    • H.I. Yoon, W.S. Koom, and I.J. Lee et al. The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinoma Liver Int 32 2012 1165 1171
    • (2012) Liver Int , vol.32 , pp. 1165-1171
    • Yoon, H.I.1    Koom, W.S.2    Lee, I.J.3
  • 52
    • 3242705230 scopus 로고    scopus 로고
    • Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis
    • H. Kato, H. Tsujii, and T. Miyamoto et al. Results of the first prospective study of carbon ion radiotherapy for hepatocellular carcinoma with liver cirrhosis Int J Radiat Oncol Biol Phys 59 2004 1468 1476
    • (2004) Int J Radiat Oncol Biol Phys , vol.59 , pp. 1468-1476
    • Kato, H.1    Tsujii, H.2    Miyamoto, T.3
  • 53
    • 77955715338 scopus 로고    scopus 로고
    • Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis
    • H. Imada, H. Kato, and S. Yasuda et al. Comparison of efficacy and toxicity of short-course carbon ion radiotherapy for hepatocellular carcinoma depending on their proximity to the porta hepatis Radiother Oncol 96 2010 231 235
    • (2010) Radiother Oncol , vol.96 , pp. 231-235
    • Imada, H.1    Kato, H.2    Yasuda, S.3
  • 54
    • 84874796373 scopus 로고    scopus 로고
    • Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - Feasibility and clinical response
    • D. Habermehl, J. Debus, and T. Ganten et al. Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response Radiat Oncol 8 2013 59
    • (2013) Radiat Oncol , vol.8 , pp. 59
    • Habermehl, D.1    Debus, J.2    Ganten, T.3
  • 55
    • 84867314318 scopus 로고    scopus 로고
    • Liver motion during cone beam computed tomography guided stereotactic body radiation therapy
    • J.C. Park, S.H. Park, and J.H. Kim et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy Med Phys 39 2012 6431 6442
    • (2012) Med Phys , vol.39 , pp. 6431-6442
    • Park, J.C.1    Park, S.H.2    Kim, J.H.3
  • 57
    • 0026558406 scopus 로고
    • Proton beams in radiation therapy
    • H. Suit, and M. Urie Proton beams in radiation therapy J Natl Cancer Inst 84 1992 155 164
    • (1992) J Natl Cancer Inst , vol.84 , pp. 155-164
    • Suit, H.1    Urie, M.2
  • 58
    • 0032862277 scopus 로고    scopus 로고
    • CT evaluation of hepatic injury following proton beam irradiation: Appearance, enhancement, and 3D size reduction pattern
    • T. Ahmadi, Y. Itai, H. Onaya, H. Yoshioka, T. Okumura, and Y. Akine CT evaluation of hepatic injury following proton beam irradiation: appearance, enhancement, and 3D size reduction pattern J Comput Assist Tomogr 23 1999 655 663
    • (1999) J Comput Assist Tomogr , vol.23 , pp. 655-663
    • Ahmadi, T.1    Itai, Y.2    Onaya, H.3    Yoshioka, H.4    Okumura, T.5    Akine, Y.6
  • 59
    • 74049132489 scopus 로고    scopus 로고
    • Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit
    • T. Fukumoto, S. Komatsu, Y. Hori, M. Murakami, Y. Hishikawa, and Y. Ku Particle beam radiotherapy with a surgical spacer placement for advanced abdominal leiomyosarcoma results in a significant clinical benefit J Surg Oncol 101 2010 97 99
    • (2010) J Surg Oncol , vol.101 , pp. 97-99
    • Fukumoto, T.1    Komatsu, S.2    Hori, Y.3    Murakami, M.4    Hishikawa, Y.5    Ku, Y.6
  • 60
    • 78650036413 scopus 로고    scopus 로고
    • Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma
    • P.J. Taddei, R.M. Howell, S. Krishnan, S.B. Scarboro, D. Mirkovic, and W.D. Newhauser Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma Phys Med Biol 55 2010 7055 7065
    • (2010) Phys Med Biol , vol.55 , pp. 7055-7065
    • Taddei, P.J.1    Howell, R.M.2    Krishnan, S.3    Scarboro, S.B.4    Mirkovic, D.5    Newhauser, W.D.6
  • 61
    • 0035083293 scopus 로고    scopus 로고
    • Intensity modulated proton therapy: A clinical example
    • A.J. Lomax, T. Boehringer, and A. Coray et al. Intensity modulated proton therapy: a clinical example Med Phys 28 2001 317 324
    • (2001) Med Phys , vol.28 , pp. 317-324
    • Lomax, A.J.1    Boehringer, T.2    Coray, A.3
  • 62
    • 69549138159 scopus 로고    scopus 로고
    • The M.D. Anderson proton therapy system
    • A. Smith, M. Gillin, and M. Bues et al. The M.D. Anderson proton therapy system Med Phys 36 2009 4068 4083
    • (2009) Med Phys , vol.36 , pp. 4068-4083
    • Smith, A.1    Gillin, M.2    Bues, M.3
  • 63
    • 33750493272 scopus 로고    scopus 로고
    • The impact of IMRT and proton radiotherapy on secondary cancer incidence
    • U. Schneider, A. Lomax, and P. Pemler et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence Strahlenther Onkol 182 2006 647 652
    • (2006) Strahlenther Onkol , vol.182 , pp. 647-652
    • Schneider, U.1    Lomax, A.2    Pemler, P.3
  • 64
    • 4544383439 scopus 로고    scopus 로고
    • The clinical potential of intensity modulated proton therapy
    • A.J. Lomax, E. Pedroni, H. Rutz, and G. Goitein The clinical potential of intensity modulated proton therapy Z Med Phys 14 2004 147 152
    • (2004) Z Med Phys , vol.14 , pp. 147-152
    • Lomax, A.J.1    Pedroni, E.2    Rutz, H.3    Goitein, G.4
  • 65
    • 84864447491 scopus 로고    scopus 로고
    • Out-of-field dose measurements in a water phantom using different radiotherapy modalities
    • R. Kaderka, D. Schardt, and M. Durante et al. Out-of-field dose measurements in a water phantom using different radiotherapy modalities Phys Med Biol 57 2012 5059 5074
    • (2012) Phys Med Biol , vol.57 , pp. 5059-5074
    • Kaderka, R.1    Schardt, D.2    Durante, M.3
  • 66
    • 84859732543 scopus 로고    scopus 로고
    • In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes
    • G. Fava, L. Widesott, and F. Fellin et al. In-gantry or remote patient positioning? Monte Carlo simulations for proton therapy centers of different sizes Radiother Oncol 103 2012 18 24
    • (2012) Radiother Oncol , vol.103 , pp. 18-24
    • Fava, G.1    Widesott, L.2    Fellin, F.3
  • 67
    • 77956329277 scopus 로고    scopus 로고
    • Special report: Workshop on 4D-treatment planning in actively scanned particle therapy - Recommendations, technical challenges, and future research directions
    • A. Knopf, C. Bert, and E. Heath et al. Special report: workshop on 4D-treatment planning in actively scanned particle therapy - recommendations, technical challenges, and future research directions Med Phys 37 2010 4608 4614
    • (2010) Med Phys , vol.37 , pp. 4608-4614
    • Knopf, A.1    Bert, C.2    Heath, E.3
  • 68
    • 84855861278 scopus 로고    scopus 로고
    • A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties
    • P.C. Park, X.R. Zhu, and A.K. Lee et al. A beam-specific planning target volume (PTV) design for proton therapy to account for setup and range uncertainties Int J Radiat Oncol Biol Phys 82 2012 e329 e336
    • (2012) Int J Radiat Oncol Biol Phys , vol.82
    • Park, P.C.1    Zhu, X.R.2    Lee, A.K.3
  • 69
    • 34248204231 scopus 로고    scopus 로고
    • Accounting for range uncertainties in the optimization of intensity modulated proton therapy
    • J. Unkelbach, T.C.Y. Chan, and T. Bortfeld Accounting for range uncertainties in the optimization of intensity modulated proton therapy Phys Med Biol 52 2007 2755 2773
    • (2007) Phys Med Biol , vol.52 , pp. 2755-2773
    • Unkelbach, J.1    Chan, T.C.Y.2    Bortfeld, T.3
  • 70
    • 80155130439 scopus 로고    scopus 로고
    • Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics
    • A.-C. Knopf, T.S. Hong, and A. Lomax Scanned proton radiotherapy for mobile targets-the effectiveness of re-scanning in the context of different treatment planning approaches and for different motion characteristics Phys Med Biol 56 2011 7257 7271
    • (2011) Phys Med Biol , vol.56 , pp. 7257-7271
    • Knopf, A.-C.1    Hong, T.S.2    Lomax, A.3
  • 71
    • 0037305954 scopus 로고    scopus 로고
    • The relative costs of proton and X-ray radiation therapy
    • M. Goitein, and M. Jermann The relative costs of proton and X-ray radiation therapy Clin Oncol (R Coll Radiol) 15 2003 S37 S50
    • (2003) Clin Oncol (R Coll Radiol) , vol.15
    • Goitein, M.1    Jermann, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.